Directory
>
Jean-Luc Girardet
Jean-Luc Girardet
Senior Vice President | Mirum Pharmaceuticals, Inc.
San Diego, California, United States
Jean-Luc Girardet
Summary
Jean-Luc Girardet is a seasoned scientific leader with over 25 years of experience in the biotechnology and pharmaceutical industries, specializing in drug discovery and development. He has played a pivotal role in the successful filing of multiple Investigational New Drug (IND) applications and New Drug Applications (NDA), notably for Zurampic and Duzallo, achieving FDA approvals. His leadership spans various roles, including Senior Vice President at Mirum Pharmaceuticals, where he oversees strategic operations for clinical and commercial programs. Jean-Luc's collaborative approach and expertise in clinical supply chain management have been instrumental in his career, particularly in due diligence activities with major pharmaceutical firms. He holds a Doctorate in Philosophy from the University of Montpellier and has contributed to significant publications in the field of medicinal chemistry. His passion for innovation in life sciences drives his commitment to advancing therapeutic solutions.
Jean-Luc Girardet
Work Experience
Senior Vice President at
Mirum Pharmaceuticals, Inc.
April 2022 - Present
Senior Vice President, Pharmaceutical Sciences at
Brii Biosciences
March 2018 - April 2022
Vice President at
Ardea Biosciences, Inc.
January 2007 - January 2018
Associate Director at
Valeant Pharmaceuticals
January 2003 - January 2007
Principal Scientist at
Ribapharm, Inc.
January 2002 - January 2003
Principal Scientist at
ICN PHARMACEUTICALS
January 1998 - January 2002
Jean-Luc Girardet
Education
University of Montpellier, Doctorates
January 1970 - January 1970
University of Michigan
January 1970 - January 1970
Université Montpellier - Ii
Frequently Asked Questions about Jean-Luc Girardet
What is Jean-Luc Girardet email address?
Jean-Luc Girardet's primary email address is *****************@briibio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Jean-Luc Girardet work for?
Jean-Luc Girardet is a Senior Vice President at Mirum Pharmaceuticals, Inc., a company specializing in Biological products, except diagnostic.
Where Jean-Luc Girardet graduated from?
Jean-Luc Girardet holds a degree in Doctor Of Philosophy from University of Montpellier.
How can I directly contact Jean-Luc Girardet?
To contact Jean-Luc Girardet directly, you can use the email address *****************@briibio.com. Complete contact information is available upon registration with Muraena.
Who is Jean-Luc Girardet?
Jean-Luc Girardet is a seasoned scientific leader with over 25 years of experience in the biotechnology and pharmaceutical industries, specializing in drug discovery and development. He has played a pivotal role in the successful filing of multiple Investigational New Drug (IND) applications and New Drug Applications (NDA), notably for Zurampic and Duzallo, achieving FDA approvals. His leadership spans various roles, including Senior Vice President at Mirum Pharmaceuticals, where he oversees strategic operations for clinical and commercial programs. Jean-Luc's collaborative approach and expertise in clinical supply chain management have been instrumental in his career, particularly in due diligence activities with major pharmaceutical firms. He holds a Doctorate in Philosophy from the University of Montpellier and has contributed to significant publications in the field of medicinal chemistry. His passion for innovation in life sciences drives his commitment to advancing therapeutic solutions.
Jean-Luc`s contact details
*****************@briibio.com
*************@mirumpharma.com
*******@mchsi.com
Colleagues
Chief Compliance Officer
Chief Operating Officer
Executive Director of Medical Affairs
Vice President
Vice President, General Manager, Italy & South Europe
Senior Vice President, North America Sales & Marketing
Executive Director. API Drug Substance Manufacturing
Executive Director, Marketing
Executive Director, Analytical Development and CMC
Executive Director, Head of Corporate Affairs